Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rathi

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Nature|October 6, 2015
Hedgehog actively maintains adult lung quiescence and regulates repair and regenerationTien Peng, David B Frank, Rachel S Kadzik, et al.
Cancers|February 13, 2020
NASA GeneLab Platform Utilized for Biological Response to Space Radiation in Animal ModelsJ Tyson McDonald, Robert Stainforth, Jack Miller, et al.
Frontiers in Oncology|March 27, 2020
CAMKV Is a Candidate Immunotherapeutic Target in <i>MYCN</i> Amplified NeuroblastomaRobyn T Sussman, Jo Lynne Rokita, Kevin Huang, et al.
Journal of the National Cancer Institute|February 26, 2020
Mitochondrial DNA Haplogroups and Susceptibility to NeuroblastomaXiao Chang, Marina Bakay, Yichuan Liu, et al.
Neoplasia (New York, N.Y.)|April 28, 2020
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinaseDongdong Chen, Julie Cox, Jayabhargav Annam, et al.
Physical Review Letters|June 4, 2008
Measurement of the reaction 2H(e,e') at 180 degrees close to the deuteron breakup thresholdN Ryezayeva, H Arenhövel, O Burda, et al.
Molecular Oncology|February 1, 2021
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic targetCara E Shields, Sindhu Potlapalli, Selma M Cuya-Smith, et al.
BMC Bioinformatics|December 15, 2020
annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusionsKrutika S Gaonkar, Federico Marini, Komal S Rathi, et al.
Cancer Research Communications|November 16, 2022
Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastomaKateryna Krytska, Colleen E Casey, Jennifer Pogoriler, et al.
Molecular Cancer Therapeutics|May 11, 2019
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical ModelsMehran Makvandi, Hwan Lee, Laura N Puentes, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Nature|October 6, 2015
Hedgehog actively maintains adult lung quiescence and regulates repair and regenerationTien Peng, David B Frank, Rachel S Kadzik, et al.
Cancers|February 13, 2020
NASA GeneLab Platform Utilized for Biological Response to Space Radiation in Animal ModelsJ Tyson McDonald, Robert Stainforth, Jack Miller, et al.
Frontiers in Oncology|March 27, 2020
CAMKV Is a Candidate Immunotherapeutic Target in <i>MYCN</i> Amplified NeuroblastomaRobyn T Sussman, Jo Lynne Rokita, Kevin Huang, et al.
Journal of the National Cancer Institute|February 26, 2020
Mitochondrial DNA Haplogroups and Susceptibility to NeuroblastomaXiao Chang, Marina Bakay, Yichuan Liu, et al.
Neoplasia (New York, N.Y.)|April 28, 2020
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinaseDongdong Chen, Julie Cox, Jayabhargav Annam, et al.
Physical Review Letters|June 4, 2008
Measurement of the reaction 2H(e,e') at 180 degrees close to the deuteron breakup thresholdN Ryezayeva, H Arenhövel, O Burda, et al.
Molecular Oncology|February 1, 2021
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic targetCara E Shields, Sindhu Potlapalli, Selma M Cuya-Smith, et al.
BMC Bioinformatics|December 15, 2020
annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusionsKrutika S Gaonkar, Federico Marini, Komal S Rathi, et al.
Cancer Research Communications|November 16, 2022
Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastomaKateryna Krytska, Colleen E Casey, Jennifer Pogoriler, et al.
Molecular Cancer Therapeutics|May 11, 2019
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical ModelsMehran Makvandi, Hwan Lee, Laura N Puentes, et al.
Pageof 12